Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Scrip 100 - Manufacturing

Turkey Jostles For Slice Of Biologics Manufacturing Pie

Many local pharma companies in Turkey have been launching capital investments in new production facilities for biologics and biosimilars in the hope of attracting new foreign partners and have already met with some success, but a number of obstacles remain.

Turkey Manufacturing Policy & Regulation

Interview: Strategies For Bio Manufacturing Partnerships

Boehringer Ingelheim’s head of BioXcellence, its contract manufacturing business, talks to Scrip about best practice when forming a long-term relationship with an outsourcing services provider.

BioPharmaceutical Manufacturing Commercial

Merck KGAA Invests €260m In Production Value Chain in China

German group Merck has inaugurated a major new pharmaceutical plant and announced a further investment in China, where it sees opportunities in essential drugs amid rising demand as the country broadens its basic healthcare coverage and its population ages.

China Manufacturing Companies
Advertisement
UsernamePublicRestriction

Register